NCT02494804
Effect of Cytokine-induced Killer Cells for Stage I-II Malignant Gliomas Not Available 1 / 2 not_yet_recruiting NCT06640582
TIL Therapy Combined With Pembrolizumab for Advanced Brain Cancer Including Gliomas and Meningiomas No drug interventions treatment 1 / 2 not_yet_recruiting NCT06270082
Study of IK-595 in RAS- or RAF-altered Advanced Tumors No drug interventions treatment 1 recruiting NCT06562621
Clinical Study on the Safety and Efficacy of Novel Oncolytic Virus in the Treatment of Recurrent Malignant Glioma treatment 1 / 2 completed NCT04327011
A Continuation Protocol for Patients Previously Enrolled in a Study of Toca 511 treatment 1 terminated NCT05475522
Intraoperative Sonographically Versus Fluorescence-guided Resection of Contrast-enhancing Gliomas and Brain Metastases No drug interventions treatment Not Available recruiting NCT06397560
PrOton Pulsed reduCed dOse Rate Radiotherapy for Recurrent CNS maligNancies Trial No drug interventions treatment Not Available not_yet_recruiting NCT05553041
18F-Fluciclovine PET-MRI in High-grade Glioma diagnostic 0 recruiting NCT06636162
Window of Opportunity Study of DSP-0390 in Gliomas No drug interventions treatment 0 not_yet_recruiting NCT05271240
Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM treatment 3 recruiting NCT05500508
Oral AMXT 1501 Dicaprate in Combination with IV DFMO treatment 1 / 2 active_not_recruiting NCT05954858
Surgical Tissue Flap to Bypass the Blood Brain Barrier in Glioblastoma No drug interventions treatment Not Available recruiting NCT05979064
Omental Tissue Autograft in Human Recurrent Glioblastoma Multiforme (rGBM) No drug interventions treatment Not Available recruiting NCT04091503
Evaluate the Safety and Effectiveness of Intranasal Administration of Temozolomide in Patients With Glioblastoma treatment 1 completed NCT04998864
Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption in GBM Patients No drug interventions Not Available Not Available unknown_status NCT05100602
Clinical Evaluation of Genetron TERT PCR Kit in Glioma Patients No drug interventions Not Available Not Available completed NCT04741984
Monocyte Antigen Carrier Cells for Newly Diagnosed GBM treatment 1 withdrawn NCT05656053
Intraoperative Rapid Diagnosis of Glioma Based on Fusion of Magnetic Resonance and Ultrasound Imaging No drug interventions Not Available Not Available active_not_recruiting NCT04547777
Phase 1 Trial of D2C7-IT in Combination With 2141-V11 for Recurrent Malignant Glioma treatment 1 recruiting NCT03392545
Combination of Immunization and Radiotherapy for Malignant Gliomas (InSituVac1) No drug interventions treatment 1 unknown_status NCT05283109
ETAPA I: Peptide-based Tumor Associated Antigen Vaccine in GBM treatment 1 recruiting NCT05406700
Niraparib In Recurrent IDH 1/2 Gliomas treatment 0 recruiting NCT04497142
Effect of Perampanel on Peritumoral Hyperexcitability in HGG treatment 1 / 2 completed NCT05896449
Predictive Values of Preoperative [68Ga]Ga-PSMA-11 PET/CT in Patients With Suspected Brain Tumours of Glial Origin No drug interventions diagnostic Not Available completed NCT06499636
In Vitro Models From Pediatric Brain Tumors No drug interventions Not Available Not Available not_yet_recruiting NCT06258018
Niraparib and Temozolomide in Patients Glioblastoma treatment 1 / 2 not_yet_recruiting NCT06196918
Efficacy and Safety of Rivaroxaban in the Prevention of Venous Thromboembolism in Glioma Patients prevention Not Available recruiting NCT05772741
Grafts of GSCs Into Brain Organoids for Testing Anti-invasion Drugs No drug interventions basic_science Not Available recruiting NCT06203496
Monitoring of Patients With Diffuse Gliomas Using Circulating miRNAs No drug interventions Not Available Not Available recruiting NCT05393258
Temporally-modulated Pulsed Radiation Therapy (TMPRT) After Prior EBRT for Recurrent IDH-mutant Gliomas No drug interventions treatment Not Available recruiting NCT05556486
Mapping of Tumor Stem Cells in the Resection Marigin During Extirpation of Highly Malignant Gliomas Using GlioStem No drug interventions Not Available Not Available recruiting NCT04541225
Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors No drug interventions treatment 1 terminated NCT03416530
ONC201 in Pediatric H3 K27M Gliomas treatment 1 active_not_recruiting NCT06381726
Personalized Rendering of Motor System Functional Plasticity Potential to Improve Glioma Resection and Quality of Life No drug interventions treatment Not Available recruiting NCT05263466
Establishing Radiolabelled PSMA as a Target for Glioma Treatment No drug interventions diagnostic Not Available not_yet_recruiting NCT05063682
The Efficacy and Safety of Brain-targeting Immune Cells (EGFRvIII-CAR T Cells) in Treating Patients With Leptomeningeal Disease From Glioblastoma. Administering Patients EGFRvIII -CAR T Cells May Help to Recognize and Destroy Brain Tumor Cells in Patients No drug interventions treatment 1 unknown_status NCT06499831
18F-FET-PET/MRI vs Standard MRI Alone for Stereotactic RadioTherapy Planning for High Grade Brain Gliomas No drug interventions diagnostic Not Available active_not_recruiting NCT05474573
Concurrent Fluorescence and Sonographically Guided Eradication of Contrast-enhancing Gliomas and Metastases No drug interventions treatment Not Available recruiting NCT06585527
Clinical Study on the Safety and Efficacy of TS-2021 in the Treatment of Recurrent Malignant Glioma No drug interventions treatment 1 recruiting NCT05695976
GRETeL: Tumor Response to Standard Radiotherapy and TMZ Patients With GBM No drug interventions Not Available Not Available recruiting NCT05366062
ERC1671 to Treat Malignant Gliomas When Given in Combination With GM-CSF, Cyclophosphamide, Bevacizumab and Pembrolizumab treatment 2 not_yet_recruiting NCT03434262
SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors treatment 1 completed NCT05557240
Neoantigens Phase I Trial in Newly Diagnosed Glioblastoma Patients treatment Not Available recruiting NCT05873946
Assessing the Effectiveness of 2D Non-Navigated Intraoperative Ultrasound in Glioma Surgery No drug interventions Not Available Not Available completed NCT04608812
Convection-enhanced Delivery of OS2966 for Patients With High-grade Glioma Undergoing a Surgical Resection treatment 1 terminated NCT03576612
GMCI, Nivolumab, and Radiation Therapy in Treating Patients With Newly Diagnosed High-Grade Gliomas treatment 1 active_not_recruiting NCT05485038
General Anesthesia Versus Awake Surgery in Resection of Gliomas and Metastases of Motor Areas No drug interventions treatment Not Available recruiting NCT04547621
HSRT and IMRT Chemoradiotherapy for Newly Diagnosed GBM treatment 1 / 2 unknown_status NCT04895553
Incidence of Intracranial Hemorrhage in Glioma Patients With Venous Thromboembolism Converted From LMWH to Apixaban No drug interventions Not Available Not Available terminated NCT04562077
Role of Surgery in Treatment of Recurrent Brian Glioma:Prognostic Factors and Outcome No drug interventions Not Available Not Available unknown_status NCT05850377
5-Aminolevulinic Acid (5-ALA) Gliolan®: Usage Increase Proposal for Neurosurgical Procedures in High-Grade Gliomas Not Available Not Available not_yet_recruiting NCT05182905
AZD1390 in Recurrent and Newly Diagnosed WHO Grade 4 Glioma Patients No drug interventions treatment 0 recruiting NCT04222309
Laparoscopically Harvested Omental Free Tissue Autograft to Bypass the Blood Brain Barrier (BBB) in Human Recurrent Glioblastoma Multiforme (rGBM) No drug interventions treatment 1 suspended NCT05267509
An Integrated Radio-immunological Approach No drug interventions Not Available Not Available recruiting NCT05076513
Trial of Niraparib in Participants With Newly-diagnosed Glioblastoma and Recurrent Glioma treatment 0 recruiting NCT05806619
Glioma: Biomolecular Aspects No drug interventions Not Available Not Available completed NCT04904419
Multi-center Research Project for Glioma Molecular Pathology Intraoperative Rapid Detection No drug interventions Not Available Not Available completed NCT05773326
Superselective Intra-arterial Cerebral Infusion of Temsirolimus in HGG treatment 0 recruiting NCT05100173
Clinical Evaluation of Genetron IDH1 PCR Kit in Glioma Patients No drug interventions Not Available Not Available completed NCT04924127
Molecular Pathology Research Project of Glioma No drug interventions Not Available Not Available completed NCT06468176
Efficacy of a Mixed Distancial Neuropsychological Rehabilitation Program in Patients With Grade 2 or 3 Diffuse Glioma No drug interventions supportive_care Not Available not_yet_recruiting NCT05764460
Social Cognition and Language in Patients With Gliomas No drug interventions Not Available Not Available not_yet_recruiting NCT06038760
Prospective Evaluation of AI R&D Tool in Adult Glioma and Other Primary Brain Tumours (PEAR-GLIO) No drug interventions Not Available Not Available recruiting NCT05226494
Safety and Tolerability of Fb-PMT in Recurrent Glioblastoma treatment 1 recruiting NCT05969691
Radiomics-Based Visualization and Quantitative Validation of IDH1 Heterogeneity in Gliomas No drug interventions other Not Available active_not_recruiting NCT06169280
Repeated Neural Stem Cell Based Virotherapy for Newly Diagnosed High Grade Glioma No drug interventions treatment 1 not_yet_recruiting NCT05772767
Modulation of Ciliogenesis in Glioma Stem Cells No drug interventions basic_science Not Available recruiting NCT05356312
Glioblastoma and Individualized Therapies No drug interventions Not Available Not Available available NCT06172595
FET PET in Differentiating Tumour Progression From Pseudoprogression in High Grade Glioma No drug interventions diagnostic 2 not_yet_recruiting NCT05555550
Evaluation of 18F-Fluciclovine Positron Emission Tomography - Magnetic Resonance Imaging (PET-MRI) in LGG diagnostic 0 not_yet_recruiting NCT06323408
Integrated Analysis of Therapy Response and Resistence in Embryonal Tumors and Gliomas No drug interventions Not Available Not Available not_yet_recruiting NCT01670890
Efficacy and Safety of TMZ Plus CDDP in the Patients With Recurrent Malignant Gliomas treatment 2 unknown_status NCT02731521
Clinical Development of MR Spectroscopy and Imaging in Brain Cancers No drug interventions Not Available Not Available completed NCT00822887
Dose Escalation Study of Vandetanib With Hypofractionated Stereotactic Radiotherapy in Recurrent Malignant Gliomas treatment 1 completed NCT00590954
Clinical and Molecular-Metabolic Phase II Trial of Perifosine for Recurrent/Progressive Malignant Gliomas treatment 2 completed NCT00165477
Study of Lenalidomide and XRT in Patients With Newly Diagnosed Glioblastoma Multiforme treatment 2 completed NCT00271609
Bevacizumab for Recurrent Malignant Glioma treatment 2 completed NCT02388659
Clinical Development of Cancer-Specific MRS Biomarkers in Malignant Gliomas No drug interventions Not Available Not Available completed NCT00923117
Sunitinib to Treat Recurrent Brain Cancer treatment 2 terminated NCT01657734
Multimodal MR Imaging in Patients With Glioblastoma Treated With Dendritic Cell Therapy No drug interventions Not Available Not Available completed NCT00704080
A Study of XL765 (SAR245409) in Combination With Temozolomide With and Without Radiation in Adults With Malignant Gliomas treatment 1 completed NCT01549392
Imaging Study of Glioblastomas Treated With Avastin No drug interventions diagnostic Not Available terminated NCT00074646
Phase I Trial of CC-8490 for the Treatment of Subjects With Recurrent/Refractory High-Grade Gliomas treatment 1 completed NCT00879437
Valproic Acid, Radiation, and Bevacizumab in Children With High Grade Gliomas or Diffuse Intrinsic Pontine Glioma treatment 2 completed NCT02155452
Fluorescence and Glioma Heterogeneity No drug interventions Not Available Not Available completed NCT02632370
5-Aminolevulinic Acid (5-ALA) to Enhance Visualization of Malignant Tumor Not Available Not Available completed NCT03212742
Phase I/IIa Study of Concomitant Radiotherapy With Olaparib and Temozolomide in Unresectable High Grade Gliomas Patients treatment 1 / 2 recruiting NCT00463073
Cetuximab, Bevacizumab and Irinotecan for Patients With Malignant Glioblastomas Not Available 2 completed NCT00671801
Irinotecan Plus Lenalidomide in Adult Patients With Recurrent Glioblastoma Multiforme: Phase I treatment 1 terminated NCT00272350
ZD6474 to Treat Advanced Brain Cancer in Patients treatment 1 completed NCT02369367
Irinotecan Plus Lenalidomide in Adult Patients With Recurrent Glioblastoma Multiforme (Phase II) treatment 2 withdrawn NCT02359565
Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma treatment 1 recruiting NCT02465268
Vaccine Therapy for the Treatment of Newly Diagnosed Glioblastoma Multiforme treatment 2 completed NCT03213678
Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial) treatment 2 active_not_recruiting NCT03919071
Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade Glioma treatment 2 recruiting NCT05099003
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG) treatment 1 / 2 recruiting NCT03155620
Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial) screening 2 recruiting NCT03581292
Veliparib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600 Mutations treatment 2 active_not_recruiting NCT03718767
Nivolumab in Patients With IDH-Mutant Gliomas With and Without Hypermutator Phenotype treatment 2 recruiting NCT03952598
Studying the Biology of IDH-mutant Gliomas Via Longitudinal Observation of 2-hydroxyglutarate (2-HG) Using MR Spectroscopy No drug interventions diagnostic Not Available recruiting NCT04817254
Association of Peripheral Blood Immunologic Response to Therapeutic Response to Adjuvant Treatment With Immune Checkpoint Inhibition (ICI) in Patients With Newly Diagnosed Glioblastoma or Gliosarcoma treatment 2 recruiting NCT05045027
Simultaneous Multinuclear Metabolic MRI in Newly Diagnosed or Recurrent Glioma No drug interventions basic_science 0 recruiting NCT04771806
Serial Advanced Magnetic Resonance Imaging Scan for Guidance of Personalized Adaptive Radiotherapy for High Grade Glioma No drug interventions Not Available Not Available recruiting NCT05030298
Preoperative Radiosurgery for the Treatment of High Grade Glioma, the NeoGlioma Study treatment 1 / 2 recruiting NCT05773664
Dexamethasone and Azeliragon for Management of Post-Resection Cerebral Edema in Patients with Glioblastoma treatment 1 withdrawn NCT06470711
Mapping of Electrical Properties in the Brain No drug interventions Not Available Not Available recruiting NCT03893903
AMPLIFYing NEOepitope-specific VACcine Responses in Progressive Diffuse Glioma treatment 1 active_not_recruiting NCT00032903
This is an Early Study to Investigate the Effect of Gimatecan® in Adults With Malignant Glioma. treatment 1 / 2 completed NCT00953121
Bevacizumab Plus Irinotecan Plus Carboplatin for Recurrent Malignant Glioma (MG) treatment 2 completed NCT00528684
Safety and Efficacy Study of REOLYSIN® in the Treatment of Recurrent Malignant Gliomas treatment 1 completed NCT02549833
Neo-adjuvant Evaluation of Glioma Lysate Vaccines in WHO Grade II Glioma treatment 1 active_not_recruiting NCT01817751
Sorafenib, Valproic Acid, and Sildenafil in Treating Patients With Recurrent High-Grade Glioma treatment 2 completed NCT00087451
Safety Study of AP23573 in Patients With Progressive or Recurrent Glioma (8669-023)(COMPLETED) treatment 1 completed NCT05717153
Intratumoral Extracellular Metabolic Impact of DFMO and AMXT 1501 in Patients With Diffuse or High Grade Glioma basic_science 0 recruiting NCT01891747
A Phase I Study of High-dose L-methylfolate in Combination With Temozolomide and Bevacizumab in Recurrent High Grade Glioma treatment 1 completed NCT05486247
Molecular Characterization of Gliomas Using a Broad Next Generation Sequencing (NGS)Panel No drug interventions Not Available Not Available completed NCT01235845
Dendritic Cell (DC) Activated Cytokine-induced Killer Cell (DCIK) Combined With DC Treatment for Glioma No drug interventions treatment 1 / 2 unknown_status NCT02457845
HSV G207 Alone or With a Single Radiation Dose in Children With Progressive or Recurrent Supratentorial Brain Tumors treatment 1 completed NCT03735498
Psychological Intervention for Caregivers of Patients With Malignant Gliomas No drug interventions supportive_care Not Available completed NCT00717197
Study of Capecitabine to Treat Recurrent High Grade Gliomas treatment 2 completed NCT05293197
Safety Study of the Repeated Opening of the Blood-brain Barrier With the SonoCloud® Device to Treat Malignant Brain Tumors in Pediatric Patients No drug interventions treatment 1 recruiting NCT02794883
Tremelimumab and Durvalumab in Combination or Alone in Treating Patients With Recurrent Malignant Glioma treatment 2 completed NCT02540161
Phase 2 Study of Sym004 for Adult Patients With Recurrent Glioblastoma treatment 2 completed NCT04013828
Treatment Decision-making in Patients With Recurrent High-grade Glioma No drug interventions Not Available Not Available completed NCT01491893
PVSRIPO for Recurrent Glioblastoma (GBM) treatment 1 completed NCT02303678
D2C7 for Adult Patients With Recurrent Malignant Glioma treatment 1 completed NCT02986178
PVSRIPO in Recurrent Malignant Glioma treatment 2 active_not_recruiting NCT03684109
Non-invasive Glioma Characterization Through Molecular Imaging No drug interventions diagnostic Not Available recruiting NCT01515085
MRI-Guided Laser Induced Thermal Therapy No drug interventions Not Available Not Available terminated NCT00919737
Study of NPC-08 is to Treat for Newly-Diagnosed Malignant Glioma and Recurrent Glioblastoma Multiforme No drug interventions treatment 1 / 2 completed NCT02300532
Post-Marketing Surveillance of Gliadel 7.7mg Implant (All-case Observational Study) No drug interventions Not Available Not Available completed NCT00589875
Phase 2a Study of CAN-2409 With Standard Radiation Therapy for Malignant Glioma treatment 2 completed NCT00751270
Phase 1b Study of AdV-tk + Valacyclovir Combined With Radiation Therapy for Malignant Gliomas treatment 1 completed NCT02300506
Post-Marketing Surveillance of Long-Term Observation of Gliadel Wafer-Investigation of Vital Prognosis in Patients With High Grade Glioma No drug interventions Not Available Not Available completed NCT01868906
FMISO-PET in Brain Tumors and SCS Effect diagnostic 2 terminated NCT00735436
A Study of Gliadel Followed by Avastin + Irinotecan for Glioblastoma Multiforme (GBM) treatment 2 terminated NCT04937413
The PCSK9i Inhibitor Evolocumab - a Surgical Trial of Pharamcodynamics and Kinetics Evaluation basic_science 0 completed NCT01351519
A Study of Aminolevulinic Acid Used to Enhance Visualization and Surgical Removal of Brain Tumors treatment 2 terminated NCT02375334
Adherence Monitoring System in Managing Myelosuppression in Patients With Newly Diagnosed Malignant Gliomas Receiving Temozolomide and Radiation Therapy No drug interventions Not Available Not Available terminated NCT01454596
CAR T Cell Receptor Immunotherapy Targeting EGFRvIII for Patients With Malignant Gliomas Expressing EGFRvIII treatment 1 / 2 completed NCT00591058
Safety and Dose-Finding Study of TM-601 in Adults With Recurrent Malignant Glioma treatment 1 unknown_status NCT01400958
Nuvigil or Placebo in Newly Diagnosed Malignant Glioma supportive_care 2 terminated NCT02047058
Treatment Response and Prognosis in Glioma Patients: Q Cell and Its Biological Characteristics No drug interventions Not Available Not Available unknown_status NCT02590263
Study Evaluating ABT-414 in Japanese Subjects With Malignant Glioma treatment 1 / 2 completed NCT02855086
Cetuximab-IRDye 800CW in Detecting Tumors in Patients With Malignant Glioma Undergoing Surgery diagnostic 1 / 2 terminated NCT00859222
LBH589 and Bevacizumab in Patients With Recurrent High Grade Glioma treatment 1 / 2 completed NCT01167322
Study of NPC-07 for Fluorescence-guided Resection of Malignant Gliomas diagnostic 3 completed NCT02861222
Myocet® in Children With Relapsed or Refractory Non-brainstem Malignant Glioma treatment 1 completed NCT03389230
Memory-Enriched T Cells in Treating Patients With Recurrent or Refractory Grade III-IV Glioma No drug interventions treatment 1 active_not_recruiting NCT00024557
Histologic Effect/Safety of Pre/Post-Operative IL13-PE38QQR in Recurrent Resectable Supratentorial Malignant Glioma Patients treatment 1 completed NCT02371031
FDOPA-PET/MRI for the Pre-operative Evaluation of Gliomas No drug interventions diagnostic 1 terminated NCT02025231
Image Guided Reirradiation of High-grade Glioma No drug interventions treatment 1 / 2 terminated NCT03778294
18F-DOPA-PET/MRI Scan in Imaging Elderly Patients With Newly Diagnosed Grade IV Malignant Glioma or Glioblastoma During Planning for a Short Course of Proton Beam Radiation Therapy treatment 2 completed NCT02644291
Phase I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric Brain Tumors treatment 1 completed NCT01386580
An Open-label, Phase I/IIa, Dose Escalating Study of 2B3-101 in Patients With Solid Tumors and Brain Metastases or Recurrent Malignant Glioma. treatment 1 / 2 completed NCT03033992
Optune for Children With High-Grade Glioma or Ependymoma, and Optune With Radiation Therapy for Children With DIPG No drug interventions treatment Not Available recruiting NCT01811992
Combined Cytotoxic and Immune-Stimulatory Therapy for Glioma No drug interventions treatment 1 completed NCT04197492
Hypofractionated Stereotactic Radiotherapy With Anlotinib in Patients With Recurrent High-Grade Gliomas treatment 2 active_not_recruiting NCT00458601
Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme treatment 2 completed NCT04175301
Effect H2 Water on QoL of Patients Receiving Radiotherapy for High Grade Gliomas. treatment 2 active_not_recruiting NCT03615404
Cytomegalovirus (CMV) RNA-Pulsed Dendritic Cells for Pediatric Patients and Young Adults With WHO Grade IV Glioma, Recurrent Malignant Glioma, or Recurrent Medulloblastoma treatment 1 completed NCT02903069
Study of Marizomib With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Brain Cancer treatment 1 completed NCT02391246
Radionecrosis and FDG PET No drug interventions Not Available Not Available unknown_status NCT01738646
Ph II SAHA and Bevacizumab for Recurrent Malignant Glioma Patients treatment 2 completed NCT04521946
Chemotherapy and Donor Stem Transplant for the Treatment of Patients With High Grade Brain Cancer treatment 1 withdrawn NCT02104310
A Pilot Study Using 18F-DOPA PET-guided Radiotherapy in Gliomas No drug interventions Not Available Not Available active_not_recruiting NCT03244995
Mind-Body Intervention in Glioma Couples No drug interventions supportive_care Not Available active_not_recruiting NCT01017250
Radiosurgery and Avastin for Recurrent Malignant Gliomas treatment Not Available completed NCT00190723
A Study of LY317615 in Patients With Brain Tumors treatment 2 completed NCT03510208
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery diagnostic 1 / 2 recruiting NCT02892708
Impact of Surgery on the Treatment of Supratentorial Malignant Gliomas in Subjects Aged 70 and Over No drug interventions treatment 3 completed NCT00157703
G207 Followed by Radiation Therapy in Malignant Glioma No drug interventions treatment 1 completed NCT00064779
Imaging Study of the Distribution of IL13-PE38QQR Infused Before and After Surgery in Adult Patients With Recurrent Malignant Glioma treatment 1 completed NCT04630379
Early Integration of Palliative Care Using the BEACON PROQOL in Patients With High Grade Glioma and Their Caregivers No drug interventions supportive_care Not Available completed NCT03973879
Combination of PVSRIPO and Atezolizumab for Adults With Recurrent Malignant Glioma treatment 1 / 2 withdrawn NCT03749187
BGB-290 and Temozolomide in Treating Isocitrate Dehydrogenase (IDH)1/2-Mutant Grade I-IV Gliomas treatment 1 recruiting NCT00041587
Pre-operative IL13-PE38QQR in Patients With Recurrent or Progressive Malignant Glioma treatment 1 / 2 completed NCT00075387
Combination Chemotherapy With or Without Sodium Thiosulfate in Preventing Low Platelet Count While Treating Patients With Malignant Brain Tumors treatment 2 unknown_status NCT02764151
First in Patient Study for PF-06840003 in Malignant Gliomas No drug interventions treatment 1 terminated NCT00766753
Vaccination-Dendritic Cells With Peptides for Recurrent Malignant Gliomas No drug interventions treatment 1 / 2 completed NCT01991977
18F-DOPA-PET in Finding Tumors in Patients With Newly Diagnosed Gliomas Undergoing Radiation Therapy diagnostic 2 active_not_recruiting NCT01249105
MK-2206 for Recurrent Malignant Glioma treatment 2 withdrawn NCT03334305
Adoptive Cellular Therapy in Pediatric Patients With High-grade Gliomas treatment 1 active_not_recruiting NCT01792505
Dendritic Cell Vaccine With Imiquimod for Patients With Malignant Glioma treatment 1 completed NCT00125697
Characterization of Serial Magnetic Resonance Spectroscopy Imaging in Patients With Malignant Glioma Undergoing Radiotherapy No drug interventions Not Available Not Available completed NCT03678883
9-ING-41 in Patients With Advanced Cancers treatment 2 active_not_recruiting NCT02507583
Antisense102: Pilot Immunotherapy for Newly Diagnosed Malignant Glioma No drug interventions treatment 1 completed NCT00683761
A Study of 131I-TM601 in Adults With Recurrent Malignant Glioma No drug interventions treatment 1 / 2 unknown_status NCT01432171
Lacosamide in Preventing Seizures in Participants With Malignant Glioma prevention Not Available terminated NCT02663271
TTFields and Pulsed Bevacizumab for Recurrent Glioblastoma treatment 2 terminated NCT02039778
Stem Cell Radiotherapy and Temozolomide for Newly Diagnosed High-grade Glioma No drug interventions treatment Not Available terminated NCT01392209
Hypofractionated Stereotactic Radiotherapy With Bevacizumab in the Treatment of Recurrent Malignant Glioma No drug interventions treatment 1 completed NCT00114309
131-I-TM-601 Study in Adults With Recurrent High-Grade Glioma treatment 2 unknown_status NCT01316809
AZD8055 for Adults With Recurrent Gliomas treatment 1 completed NCT04109209
Psychological Intervention For Brain Tumor Caregivers No drug interventions supportive_care Not Available completed NCT03299309
PEP-CMV in Recurrent MEdulloblastoma/Malignant Glioma No drug interventions treatment 1 active_not_recruiting NCT00782756
Bevacizumab, Temozolomide and Hypofractionated Radiotherapy for Patients With Newly Diagnosed Malignant Glioma No drug interventions treatment 2 completed NCT00283556
High Dose Camptothecin-11 (CPT-11) in Recurrent Unresectable Malignant Glioma treatment 1 / 2 completed NCT02659800
Study of the Effect NT-I7 on CD4 Counts in Patients With High Grade Gliomas supportive_care 1 terminated NCT00024570
Interstitial Infusion of IL13-PE38QQR Cytotoxin in Recurrent Malignant Glioma treatment 1 / 2 completed NCT03956706
Study of Stereotactic Radiosurgery to the Subventricular Zone in Malignant Gliomas No drug interventions treatment Not Available withdrawn NCT04943718
Personalized Vaccine for Patients With Recurrent Malignant Glioma No drug interventions treatment 1 unknown_status NCT02526017
Study of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced Cancers treatment 1 completed NCT03501134
Quality of Life of Patients With Glioblastoma (GBM) Treated With Tumor-Treating Fields No drug interventions Not Available Not Available completed NCT01740258
Bevacizumab Beyond Progression (BBP) treatment 2 completed NCT03220035
Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial) treatment 2 active_not_recruiting NCT01303835
Low Dose Naltrexone for Glioma Patients treatment 2 completed NCT01952886
Patient Satisfaction, Efficacy and Compliance of Antiemetic Patch vs Pill in Malignant Glioma Patients supportive_care 2 withdrawn NCT00900757
Intravenous Palonosetron With Radiotherapy and Concomitant Temozolomide prevention 2 completed NCT01004874
Avastin/Radiation (XRT)/Temozolomide (Temodar) Followed by Avastin/Temodar/Topotecan for Glioblastoma treatment 2 completed NCT01808820
Dendritic Cell (DC) Vaccine for Malignant Glioma and Glioblastoma treatment 1 completed NCT03387020
Ribociclib and Everolimus in Treating Children With Recurrent or Refractory Malignant Brain Tumors treatment 1 completed NCT02020720
18F-DOPA-PET in Planning Surgery in Patients With Gliomas No drug interventions diagnostic 0 active_not_recruiting NCT02661282
Autologous CMV-Specific Cytotoxic T Cells and Temozolomide in Treating Patients With Glioblastoma treatment 1 / 2 completed NCT02311582
MK-3475 in Combination With MRI-guided Laser Ablation in Recurrent Malignant Gliomas treatment 1 / 2 completed NCT01266031
Phase I/II Adaptive Randomized Trial of Bevacizumab Versus Bevacizumab Plus Vorinostat in Adults With Recurrent Glioblastoma treatment 1 / 2 completed NCT00634231
A Phase I Study of AdV-tk + Prodrug Therapy in Combination With Radiation Therapy for Pediatric Brain Tumors treatment 1 completed NCT02829931
Hypofractionated Stereotactic Irradiation With Nivolumab, Ipilimumab and Bevacizumab in Patients With Recurrent High Grade Gliomas treatment 1 completed NCT04160494
D2C7-IT With Atezolizumab for Recurrent Gliomas treatment 1 active_not_recruiting NCT03043391
Phase 1b Study PVSRIPO for Recurrent Malignant Glioma in Children treatment 1 completed NCT02330562
Stage 1: Marizomib + Bevacizumab in WHO Gr IV GBM; Stage 2: Marizomib Alone; Stage 3: Combination of Marizomib and Bevacizumab treatment 1 / 2 completed NCT02186262
Rotating Frame Relaxation and Diffusion Weighted Imaging of Human Gliomas No drug interventions Not Available Not Available completed NCT03746080
Whole Brain Radiation Therapy With Standard Temozolomide Chemo-Radiotherapy and Plerixafor in Treating Patients With Glioblastoma treatment 2 active_not_recruiting NCT02323880
Selinexor in Treating Younger Patients With Recurrent or Refractory Solid Tumors or High-Grade Gliomas treatment 1 active_not_recruiting NCT02315989
Early-Phase Safety of Proton Therapy Equipment No drug interventions treatment Not Available completed NCT00766467
A Randomized Placebo-Controlled Trial of Armodafinil (Nuvigil) for Fatigue in Patients With Malignant Gliomas supportive_care 2 completed NCT04650204
Perampanel for the Reduction of Seizure Frequency in Patients With High-grade Glioma and Focal Epilepsy prevention 4 terminated NCT03233204
Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial) treatment 2 completed NCT02529072
Nivolumab With DC Vaccines for Recurrent Brain Tumors treatment 1 completed NCT02313272
Hypofractionated Stereotactic Irradiation (HFSRT) With Pembrolizumab and Bevacizumab for Recurrent High Grade Gliomas treatment 1 completed NCT05660369
CARv3-TEAM-E T Cells in Glioblastoma No drug interventions treatment 1 recruiting NCT03471546
Early Palliative Care Intervention in Malignant Glioma No drug interventions supportive_care Not Available completed NCT00576446
Surgical Resection With Gliadel Wafer Followed by Dendritic Cells Vaccination for Malignant Glioma Patients No drug interventions treatment 1 completed NCT04323046
Immunotherapy Before and After Surgery for Treatment of Recurrent or Progressive High Grade Glioma in Children and Young Adults treatment 1 recruiting NCT02023346
Prognostic Awareness and Patient-Physician Communication in Malignant Glioma No drug interventions Not Available Not Available completed NCT03915912
Mindfulness Meditation in Glioma Patients No drug interventions supportive_care Not Available completed NCT00125710
Comparative 2-D Tumor Analysis in Familial Gliomas No drug interventions Not Available Not Available completed NCT02278510
Topotecan Using Convection-Enhanced Delivery (CED) in High Grade Glioma treatment 0 completed NCT04903795
Bispecific T Cell Engager BRiTE for Patients With Grade IV Malignant Glioma No drug interventions treatment 1 not_yet_recruiting NCT03411408
Accelerated Hypofractionated Intensity - Modulated Radiotherapy After Hyperbaric Oxygenation for Recurrent High Grade Glioma. No drug interventions treatment Not Available recruiting NCT00103038
Ferumoxytol in Improving MR Imaging in Patients With High-Grade Brain Tumors or Cerebral Metastases diagnostic Not Available completed NCT02924038
A Study of Varlilumab and IMA950 Vaccine Plus Poly-ICLC in Patients With WHO Grade II Low-Grade Glioma (LGG) treatment 1 terminated